RO7303509 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05462522 (ClinicalTrials.gov)	January 16, 2023	14/7/2022	A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509in Participants With ...	A Phase Ib, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety, ...	Systemic Sclerosis	Drug: RO7303509;Drug: Placebo	Genentech, Inc.	NULL	Recruiting	18 Years	75 Years	All	100	Phase 1	United States;Belgium;France;Israel;Poland;Puerto Rico;Spain

First Previous1Next Last